➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Harvard Business School
Colorcon
Moodys
Dow

Last Updated: June 18, 2021

DrugPatentWatch Database Preview

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Drug Profile


Email this page to a colleague

« Back to Dashboard

When do Dorzolamide Hydrochloride And Timolol Maleate patents expire, and what generic alternatives are available?

Dorzolamide Hydrochloride And Timolol Maleate is a drug marketed by Akorn, Aurobindo Pharma Ltd, Bausch And Lomb, Fdc Ltd, Indoco, Lannett Co Inc, Micro Labs, Rubicon, Sandoz, Sandoz Inc, Somerset, Teva Pharms, and Zambon Spa. and is included in fourteen NDAs.

The generic ingredient in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.

Summary for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
US Patents:0
Applicants:13
NDAs:14
Finished Product Suppliers / Packagers: 12
Clinical Trials: 9
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE?DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE excipients list
DailyMed Link:DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE at DailyMed
Drug patent expirations by year for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Recent Clinical Trials for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of FloridaPhase 1
AllerganPhase 3
Meir Medical CenterN/A

See all DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE clinical trials

Pharmacology for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

US Patents and Regulatory Information for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 077847-001 Oct 28, 2008 AT RX No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
Lannett Co Inc DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 201998-001 Dec 17, 2014 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
Bausch And Lomb DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 090037-001 Jul 14, 2009 AT RX No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Colorcon
Johnson and Johnson
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.